Fmoc-D-alanine is the 9-fluorenylmethoxycarbonyl-protected derivative of D-alanine, CAS 79990-15-1, molecular formula C18H17NO4, and molecular weight 311.33 g/mol for the anhydrous free acid. The monohydrate form has a molecular weight of 329.35 g/mol and contains 1 mol of water per mole of protected amino acid, equivalent to a theoretical water content of 5.47% by mass. The Fmoc chromophore absorbs in the near-ultraviolet region with a maximum near 301 nm, which permits direct UV monitoring of deprotection and residual Fmoc adduct removal during solid-phase peptide synthesis. The material is used as a chiral building block in Fmoc-based solid-phase peptide synthesis, where the D configuration of alanine must be retained without racemization during activation and chain elongation.

Commercial models for this product are not interchangeable because hydration state, residual solvent profile, and grade designation affect charging accuracy. The anhydrous free acid and the monohydrate share the same CAS registry, but differ by 18.02 g/mol in molecular weight. If a peptide synthesizer calculates reagent delivery by mass and the operator selects the wrong molecular weight, the delivered stoichiometry shifts by approximately 5.5% relative to the target, which is a significant error for sequences longer than 20 residues. Supplier grades may be labeled as research-grade, high-purity, or GMP-compliant; the last is controlled under ICH Q7 when the peptide is intended as an active pharmaceutical ingredient. The model differentiation therefore lies in the certificate of analysis, not only in the chemical name.

The compound is a carbamate-protected amino acid, meaning the Fmoc group is attached to the α-nitrogen through a carbonyl group. This carbamate structure lowers the tendency of the activated intermediate to form an oxazolone, which is a central mechanism of α-carbon racemization in amino acid coupling. In solution-phase activation of Fmoc-D-alanine with aminium reagents, the carbamate nitrogen remains less basic than a free amine, so the formation of a racemizing oxazolone is suppressed relative to acyl-protected alanine derivatives. This property is relevant when the building block is used for peptide sequences that are sensitive to diastereomer formation.

Specification parameters are typically anchored to a combination of liquid chromatography, mass spectrometry, and titrimetric methods. The abbreviated release criteria in Table 1 reflect commonly disclosed supplier specifications for Fmoc-D-alanine free acid.

Reverse-phase HPLC purity is not sufficient to establish enantiomeric identity. Fmoc-D-alanine and Fmoc-L-alanine have identical retention times on conventional C18 columns; therefore a chiral stationary phase is required to quantify the undesired L-enantiomer. Mass spectrometry confirms molecular identity but does not distinguish the two enantiomers. Specific optical rotation is usually reported on the certificate of analysis, but the measured value depends on solvent, concentration, and temperature. Consequently, the enantiomeric purity result from chiral HPLC is the critical release parameter for peptide API quality, particularly for peptides containing D-alanine residues intended to modulate proteolytic stability.

For peptide APIs intended for human use, raw material release is evaluated under ICH Q7 and the receiving facility’s quality system under 21 CFR 210/211 for finished pharmaceuticals. Specification limits are justified under ICH Q6A principles, and residual solvents are controlled to ICH Q3C limits. These references are not unique to Fmoc-D-alanine but define the regulatory boundary for using the material in validated peptide manufacturing.

What Distinguishes Fmoc-D-alanine from the L-Enantiomer and the Boc-Protected Analog?

The difference between Fmoc-D-alanine and Fmoc-L-alanine is stereochemical, not formulaic. Both compounds share the same molecular weight, the same UV chromophore, and similar solubility in dipolar aprotic solvents such as dimethylformamide and N-methyl-2-pyrrolidone. In solid-phase peptide synthesis, Fmoc-D-alanine introduces a D-configured alanine residue into the growing chain, while Fmoc-L-alanine introduces the naturally abundant L configuration. The stereochemical outcome affects backbone torsion angles, intramolecular hydrogen bonding, and susceptibility to proteolytic enzymes. A residual Fmoc-L-alanine content above 0.5% in a D-alanine building block can be propagated as a sequence impurity and may be difficult to remove by standard HPLC purification if the retention time of the resulting peptide diastereomer is close to the target peptide.

Fmoc-D-alanine and Boc-D-alanine differ in the amino-protecting group and therefore in the overall synthesis regime. The Fmoc group is removed under basic conditions, typically with 20% piperidine in DMF, while the Boc group is removed under acidic conditions, typically with trifluoroacetic acid or hydrochloric acid in dioxane. Fmoc protection is compatible with acid-labile side-chain protecting groups and final cleavage with TFA-based cocktails, which is the basis of the Fmoc strategy. Boc protection is used in classical solid-phase synthesis with hydrogen fluoride or strong acid cleavage. The two forms are not directly interchangeable in a single synthesis route without changing the global protection scheme.

Fmoc-D-alanine also differs from preactivated esters such as Fmoc-D-alanine pentafluorophenyl ester or Fmoc-D-alanine N-hydroxysuccinimide ester. These are more moisture-sensitive and are used for difficult coupling steps or fragment condensation, but they are not the same product and require different storage and handling. Preloaded 2-chlorotrityl or Wang resins containing Fmoc-D-alanine are downstream materials that reduce initial loading steps but limit the user’s control over substitution density and loading efficiency. These alternatives do not replace the free acid when the target sequence needs a precise molar ratio or when the synthesis route specifies solution-phase activation.

If Fmoc-D-alanine Is Used on Automated Microwave or Classical Batch Synthesizers

On automated synthesizers with single-use reactor vessels, the physical form of Fmoc-D-alanine influences dissolution rate and transfer efficiency. The crystalline solid is typically dissolved in DMF or N-methyl-2-pyrrolidone before being loaded into amino acid vials. For microwave-assisted coupling, a stock solution of 0.2 M to 0.5 M Fmoc-D-alanine in DMF is common, with activation by aminium or phosphonium reagents such as HATU or PyBOP in the presence of N,N-diisopropylethylamine or N-methylmorpholine. The solution must be prepared fresh or kept under low moisture conditions, because Fmoc-D-alanine can precipitate from cold DMF and because the activated ester hydrolyzes in the presence of free water.

For resin loading onto Wang-type supports, Fmoc-D-alanine is often attached through an ester linkage using N,N'-diisopropylcarbodiimide and a catalytic amount of 4-dimethylaminopyridine. The reaction is exothermic and can lead to a small amount of epimerization at the α-carbon if the 4-dimethylaminopyridine concentration is high or if the temperature is not controlled. This is a critical threshold: the formation of Fmoc-L-alanine during loading can be minimized by using low temperature (0–4 °C), a short activation time, and a 4-dimethylaminopyridine concentration typically maintained below 0.1 M. Published data for this specific configuration is limited, but the mechanism is analogous to other Fmoc-amino acid esterifications on Wang resin.

After coupling, the Fmoc group is removed with 20% piperidine in DMF. The Fmoc-D-alanine residue is stable to the basic deprotection conditions for short cycles, but prolonged exposure to piperidine beyond 30–60 min should be avoided on automated systems that pause, because the peptide-resin may undergo diketopiperazine formation at the C-terminal dipeptide stage, particularly if Fmoc-D-alanine is at the second position from a hydroxylic or thiol-functionalized resin. Diketopiperazine formation is sequence-dependent and can result in low resin loading or cleavage of the protected dipeptide.

The alanine side chain is a methyl group and does not require acid-labile protection. Therefore Fmoc-D-alanine can be cleaved from the resin with standard TFA cocktails such as TFA/water/triisopropylsilane (95:2.5:2.5, v/v/v) without the risk of side-chain deprotection or rearrangement. This is different from building blocks with side-chain protecting groups such as Fmoc-Lys(Boc)-OH or Fmoc-Ser(tBu)-OH, where incomplete scavenger removal can lead to byproduct alkylation.

Coupling efficiency can be monitored by UV spectrophotometric measurement of the released Fmoc-piperidine adduct at 301 nm. On classic batch synthesizers equipped with a flow-through UV cell, a reduction in the integrated peak area relative to the previous cycle indicates incomplete Fmoc-D-alanine incorporation. When the target sequence contains multiple consecutive alanine residues, incomplete coupling may require a double-coupling step or a capping step with acetic anhydride/pyridine to terminate the unreacted amino terminus.

During manual coupling, the activated amino acid solution should be added to the resin within the pot-life of the activated ester. For HATU-mediated activation of Fmoc-D-alanine in DMF, the active species is generated at low temperature and is typically consumed within 3–10 min at room temperature, depending on concentration and moisture content. Prolonged standing of the activated solution before addition can lead to reduced coupling yield and increased hydrolysis to the free acid, which is unreactive toward the resin-bound amine. This loss is not visible by eye and only becomes apparent when the subsequent deprotection UV trace or Kaiser test indicates incomplete coupling.

Storage Boundaries and Incompatibility with Bases and Moisture

Fmoc-D-alanine is stored at 2–8 °C in tightly closed containers under an inert gas such as argon or nitrogen. Before a cold container is opened, the solid should be allowed to warm to 20–25 °C to prevent atmospheric moisture from condensing onto the powder. The compound is hygroscopic enough that repeated opening of the same bottle under high relative humidity can increase water content and reduce the effective molar mass; this is particularly relevant for anhydrous material. The moisture barrier is not an absolute requirement for short-term use, but at relative humidity above 60%, pre-drying in a vacuum desiccator over phosphorus pentoxide or silica gel may be required before gravimetric charging.

The Fmoc group is base-labile and is removed by secondary amines. The product must not be stored near volatile bases such as diethylamine, triethylamine, piperidine, or ammonia, because traces of these bases can cause premature Fmoc cleavage and reduce effective purity. Contact with strong acids can protonate the alanine carboxylate and alter solubility, but does not cleave the Fmoc group under short exposure. The compound is stable to TFA used in final resin cleavage, which is why Fmoc chemistry is compatible with acid-labile side-chain protection.

Batch-to-batch variability in residual DMF, ethyl acetate, or methanol is controlled by the supplier but can affect coupling performance in automated synthesizers. A batch with elevated residual DMF may appear sticky and resist uniform dissolution; a batch with elevated water content can reduce the concentration of activated ester. For GMP peptide manufacturing, the residual solvent profile should be evaluated against ICH Q3C limits and the specific synthetic route before release. The analytical certificate of analysis is the only reliable source of these values; generic product descriptions do not capture this variability.

The main organic impurities in Fmoc-D-alanine are typically the protected dipeptide Fmoc-D-Ala-D-Ala and the L-enantiomer. For specification-setting under ICH Q6A, individual impurity limits are sometimes set at ≤0.2% for the L-enantiomer and ≤0.5% for total unknown impurities when the peptide is intended as an API. Published data for Fmoc-D-alanine-specific impurity profiles is limited; the acceptance criteria are usually established from process capability data rather than compendial monographs.

For acidic final cleavage, Fmoc-D-alanine-containing peptides are treated with TFA-based cocktails that vary with the scavenger system. The methyl side chain of alanine does not generate reactive intermediates during cleavage, so the scavenger is present mainly for other side-chain protecting groups and for cation trapping. This behavior is different from protected residues such as cysteine or methionine, where oxidation and alkylation byproducts are major concerns during acidic cleavage.